[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES542565A0 - Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas. - Google Patents

Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.

Info

Publication number
ES542565A0
ES542565A0 ES542565A ES542565A ES542565A0 ES 542565 A0 ES542565 A0 ES 542565A0 ES 542565 A ES542565 A ES 542565A ES 542565 A ES542565 A ES 542565A ES 542565 A0 ES542565 A0 ES 542565A0
Authority
ES
Spain
Prior art keywords
sub
alkyl
ocfidrotiazolo
guinolins
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542565A
Other languages
English (en)
Other versions
ES8704177A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8704177A1 publication Critical patent/ES8704177A1/es
Publication of ES542565A0 publication Critical patent/ES542565A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/30Metal salts; Chelates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES542565A 1984-04-27 1985-04-25 Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas. Expired ES8704177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/604,687 US4537893A (en) 1984-04-27 1984-04-27 Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors

Publications (2)

Publication Number Publication Date
ES8704177A1 ES8704177A1 (es) 1987-03-16
ES542565A0 true ES542565A0 (es) 1987-03-16

Family

ID=24420601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542565A Expired ES8704177A1 (es) 1984-04-27 1985-04-25 Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.

Country Status (19)

Country Link
US (1) US4537893A (es)
EP (1) EP0160502B1 (es)
JP (1) JPH0631262B2 (es)
KR (1) KR870001072B1 (es)
CN (1) CN85101547A (es)
AT (1) ATE67767T1 (es)
AU (1) AU564946B2 (es)
CA (1) CA1287356C (es)
DE (1) DE3584183D1 (es)
DK (1) DK185485A (es)
ES (1) ES8704177A1 (es)
GR (1) GR850989B (es)
HU (1) HU193113B (es)
IL (1) IL74988A0 (es)
NZ (1) NZ211863A (es)
PH (1) PH21951A (es)
PT (1) PT80339B (es)
SU (1) SU1414318A3 (es)
ZA (1) ZA852999B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778894A (en) * 1983-09-26 1988-10-18 Eli Lilly And Company 6 oxo-decahydroquinolines
US4977160A (en) * 1986-06-16 1990-12-11 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US5134143A (en) * 1986-06-16 1992-07-28 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
DE3624607A1 (de) * 1986-07-21 1988-01-28 Boehringer Ingelheim Kg Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5006525A (en) * 1989-07-24 1991-04-09 Eli Lilly And Company Dopamine agonists method
US4977149A (en) * 1989-07-24 1990-12-11 Eli Lilly And Company Pyridoquinoline dopamine agonists, compositions and use
US5057515A (en) * 1989-07-24 1991-10-15 Eli Lilly And Company Method for agonizing a dopamine receptor
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
EP0816406B1 (de) * 1996-06-26 2000-09-06 Bayer Ag Verfahren zur Herstellung salzarmer Präparationen von Kondensationsprodukten
CN102088998A (zh) * 2008-05-14 2011-06-08 益普生制药股份有限公司 生长激素释放抑制因子-多巴胺缀合物的药物组合物
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2056224A1 (de) * 1969-11-17 1971-06-03 Danchi Seiyaku Co , Ltd , Tokio Neue Thiazolochinohnderivate und Ver fahren zu ihrer Herstellung
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
US4258049A (en) * 1979-07-02 1981-03-24 Smithkline Corporation Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
US4367231A (en) * 1979-09-14 1983-01-04 Eli Lilly And Company Method of using octahydro pyrazolo[3,4-g]quinolines

Also Published As

Publication number Publication date
CA1287356C (en) 1991-08-06
PH21951A (en) 1988-04-15
EP0160502A3 (en) 1987-03-11
IL74988A0 (en) 1985-08-30
DE3584183D1 (de) 1991-10-31
CN85101547A (zh) 1987-01-24
PT80339B (en) 1987-02-16
EP0160502B1 (en) 1991-09-25
HU193113B (en) 1987-08-28
GR850989B (es) 1985-11-25
DK185485A (da) 1985-10-28
HUT37624A (en) 1986-01-23
AU564946B2 (en) 1987-09-03
KR870001072B1 (ko) 1987-05-27
EP0160502A2 (en) 1985-11-06
PT80339A (en) 1985-05-01
ES8704177A1 (es) 1987-03-16
JPH0631262B2 (ja) 1994-04-27
DK185485D0 (da) 1985-04-25
JPS60233091A (ja) 1985-11-19
KR850007261A (ko) 1985-12-02
NZ211863A (en) 1987-10-30
ZA852999B (en) 1986-11-26
US4537893A (en) 1985-08-27
AU4166685A (en) 1985-10-31
ATE67767T1 (de) 1991-10-15
SU1414318A3 (ru) 1988-07-30

Similar Documents

Publication Publication Date Title
ES542565A0 (es) Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.
GB1423006A (en) Herbicidal compositions containing 4-phenoxy-phenoxy-propionic acid derivatives
ES541557A0 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro-1,5-benzotiazepina
DE3687288D1 (de) Chinuclidinderivate.
KR830005187A (ko) 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법
KR850001171A (ko) 퀴놀린 화합물의 제조방법
AU6747687A (en) New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
SE8302347D0 (sv) Bensoazacykloalkyl-spiro-imidazolidiner, framstellning derav och farmaceutiska kompositioner innehallande dem
ES529069A0 (es) Procedimiento de preparar nuevos derivados de sales inertes de hidroxido de aminopiridinio y sus sales correspondientes
ES533320A0 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
KR840004422A (ko) 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법
ES515106A0 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
KR860001815A (ko) 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법
ES530073A0 (es) Procedimiento para preparar la n-(3-trifluorometil fenil)-n-propargil-piperazina.
DK469285A (da) Thiadiazolderivater, der indvirker paa centralnervesystemet, fremgangsmaade til fremstilling deraf og midler indeholdende derivaterne
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
ES8706623A1 (es) Procedimiento de preparar compuestos amidicos farmacologicamente activos
SE8501993D0 (sv) New apovincaminol derivatives, process for their preparation and pharmaceutical compositions containing them
RU95117134A (ru) Производное морфолина или его фармацевтически приемлемая соль и фармацевтическая композиция на его основе
KR850002479A (ko) 피리미도 [4,5-g] 퀴놀린 유도체의 제조방법

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612